カテゴリー： Market Monitor Global, 世界, 医療/バイオ

フォスタマチニブの世界市場見通し2023年-2029年

◆英語タイトル：Fostamatinib Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5572）

◆商品コード：MMG23JU5572
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Fostamatinib Market 調査レポートは次の情報を含め、グローバルにおけるのフォスタマチニブ市場規模と予測を収録しています。・世界のフォスタマチニブ市場：売上、2018年-2023年、2024年-2029年
・世界のフォスタマチニブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のフォスタマチニブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「タヴァリス」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

フォスタマチニブのグローバル主要企業は、Rigel Pharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、フォスタマチニブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のフォスタマチニブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ市場：タイプ別市場シェア、2022年
・タヴァリス、タヴレッセ

世界のフォスタマチニブ市場：用途別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ市場：用途別市場シェア、2022年
・特発性（免疫性）血小板減少性紫斑病、ワルデンストレームマクログロブリン血症、自己免疫性溶血性貧血、その他

世界のフォスタマチニブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のフォスタマチニブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるフォスタマチニブのグローバル売上、2018年-2023年
・主要企業におけるフォスタマチニブのグローバル売上シェア、2022年
・主要企業におけるフォスタマチニブのグローバル販売量、2018年-2023年
・主要企業におけるフォスタマチニブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Rigel Pharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca

*************************************************************

・調査・分析レポートの概要
フォスタマチニブ市場の定義
市場セグメント
世界のフォスタマチニブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のフォスタマチニブ市場規模
世界のフォスタマチニブ市場規模：2022年 VS 2029年
世界のフォスタマチニブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのフォスタマチニブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のフォスタマチニブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：タヴァリス、タヴレッセ
フォスタマチニブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：特発性（免疫性）血小板減少性紫斑病、ワルデンストレームマクログロブリン血症、自己免疫性溶血性貧血、その他
フォスタマチニブの用途別グローバル売上・予測

・地域別市場分析
地域別フォスタマチニブ市場規模 2022年と2029年
地域別フォスタマチニブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Rigel Pharmaceuticals, Inc、 Kissei Pharmaceutical Co., Ltd、 Grifols、 JW Pharmaceutical Corporation、 Medison Pharma Canada、 AstraZeneca
...

This report aims to provide a comprehensive presentation of the global market for Fostamatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fostamatinib. This report contains market size and forecasts of Fostamatinib in global, including the following market information:
Global Fostamatinib Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Fostamatinib Market Sales, 2018-2023, 2024-2029, (K Bottles)
Global top five Fostamatinib companies in 2022 (%)
The global Fostamatinib market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tavalisse Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Fostamatinib include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fostamatinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Fostamatinib Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Type, 2022 (%)
Tavalisse
Tavlesse
Global Fostamatinib Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, by Application, 2022 (%)
Idiopathic (Immune) Thrombocytopenic Purpura
Waldenström’s Macroglobulinemia
Autoimmune Haemolytic Anaemia
Other
Global Fostamatinib Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Bottles)
Global Fostamatinib Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fostamatinib revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Fostamatinib revenues share in global market, 2022 (%)
Key companies Fostamatinib sales in global market, 2018-2023 (Estimated), (K Bottles)
Key companies Fostamatinib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Rigel Pharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
Grifols
JW Pharmaceutical Corporation
Medison Pharma Canada
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fostamatinib, market overview.
Chapter 2: Global Fostamatinib market size in revenue and volume.
Chapter 3: Detailed analysis of Fostamatinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fostamatinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Fostamatinib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Fostamatinib Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fostamatinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fostamatinib Overall Market Size
2.1 Global Fostamatinib Market Size: 2022 VS 2029
2.2 Global Fostamatinib Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Fostamatinib Sales: 2018-2029
3 Company Landscape
3.1 Top Fostamatinib Players in Global Market
3.2 Top Global Fostamatinib Companies Ranked by Revenue
3.3 Global Fostamatinib Revenue by Companies
3.4 Global Fostamatinib Sales by Companies
3.5 Global Fostamatinib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Fostamatinib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Fostamatinib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Fostamatinib Players in Global Market
3.8.1 List of Global Tier 1 Fostamatinib Companies
3.8.2 List of Global Tier 2 and Tier 3 Fostamatinib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Fostamatinib Market Size Markets, 2022 & 2029
4.1.2 Tavalisse
4.1.3 Tavlesse
4.2 By Type – Global Fostamatinib Revenue & Forecasts
4.2.1 By Type – Global Fostamatinib Revenue, 2018-2023
4.2.2 By Type – Global Fostamatinib Revenue, 2024-2029
4.2.3 By Type – Global Fostamatinib Revenue Market Share, 2018-2029
4.3 By Type – Global Fostamatinib Sales & Forecasts
4.3.1 By Type – Global Fostamatinib Sales, 2018-2023
4.3.2 By Type – Global Fostamatinib Sales, 2024-2029
4.3.3 By Type – Global Fostamatinib Sales Market Share, 2018-2029
4.4 By Type – Global Fostamatinib Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fostamatinib Market Size, 2022 & 2029
5.1.2 Idiopathic (Immune) Thrombocytopenic Purpura
5.1.3 Waldenström’s Macroglobulinemia
5.1.4 Autoimmune Haemolytic Anaemia
5.1.5 Other
5.2 By Application – Global Fostamatinib Revenue & Forecasts
5.2.1 By Application – Global Fostamatinib Revenue, 2018-2023
5.2.2 By Application – Global Fostamatinib Revenue, 2024-2029
5.2.3 By Application – Global Fostamatinib Revenue Market Share, 2018-2029
5.3 By Application – Global Fostamatinib Sales & Forecasts
5.3.1 By Application – Global Fostamatinib Sales, 2018-2023
5.3.2 By Application – Global Fostamatinib Sales, 2024-2029
5.3.3 By Application – Global Fostamatinib Sales Market Share, 2018-2029
5.4 By Application – Global Fostamatinib Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Fostamatinib Market Size, 2022 & 2029
6.2 By Region – Global Fostamatinib Revenue & Forecasts
6.2.1 By Region – Global Fostamatinib Revenue, 2018-2023
6.2.2 By Region – Global Fostamatinib Revenue, 2024-2029
6.2.3 By Region – Global Fostamatinib Revenue Market Share, 2018-2029
6.3 By Region – Global Fostamatinib Sales & Forecasts
6.3.1 By Region – Global Fostamatinib Sales, 2018-2023
6.3.2 By Region – Global Fostamatinib Sales, 2024-2029
6.3.3 By Region – Global Fostamatinib Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Fostamatinib Revenue, 2018-2029
6.4.2 By Country – North America Fostamatinib Sales, 2018-2029
6.4.3 US Fostamatinib Market Size, 2018-2029
6.4.4 Canada Fostamatinib Market Size, 2018-2029
6.4.5 Mexico Fostamatinib Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Fostamatinib Revenue, 2018-2029
6.5.2 By Country – Europe Fostamatinib Sales, 2018-2029
6.5.3 Germany Fostamatinib Market Size, 2018-2029
6.5.4 France Fostamatinib Market Size, 2018-2029
6.5.5 U.K. Fostamatinib Market Size, 2018-2029
6.5.6 Italy Fostamatinib Market Size, 2018-2029
6.5.7 Russia Fostamatinib Market Size, 2018-2029
6.5.8 Nordic Countries Fostamatinib Market Size, 2018-2029
6.5.9 Benelux Fostamatinib Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Fostamatinib Revenue, 2018-2029
6.6.2 By Region – Asia Fostamatinib Sales, 2018-2029
6.6.3 China Fostamatinib Market Size, 2018-2029
6.6.4 Japan Fostamatinib Market Size, 2018-2029
6.6.5 South Korea Fostamatinib Market Size, 2018-2029
6.6.6 Southeast Asia Fostamatinib Market Size, 2018-2029
6.6.7 India Fostamatinib Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Fostamatinib Revenue, 2018-2029
6.7.2 By Country – South America Fostamatinib Sales, 2018-2029
6.7.3 Brazil Fostamatinib Market Size, 2018-2029
6.7.4 Argentina Fostamatinib Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Fostamatinib Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Fostamatinib Sales, 2018-2029
6.8.3 Turkey Fostamatinib Market Size, 2018-2029
6.8.4 Israel Fostamatinib Market Size, 2018-2029
6.8.5 Saudi Arabia Fostamatinib Market Size, 2018-2029
6.8.6 UAE Fostamatinib Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Rigel Pharmaceuticals, Inc
7.1.1 Rigel Pharmaceuticals, Inc Company Summary
7.1.2 Rigel Pharmaceuticals, Inc Business Overview
7.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Major Product Offerings
7.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Sales and Revenue in Global (2018-2023)
7.1.5 Rigel Pharmaceuticals, Inc Key News & Latest Developments
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Summary
7.2.2 Kissei Pharmaceutical Co., Ltd Business Overview
7.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Major Product Offerings
7.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales and Revenue in Global (2018-2023)
7.2.5 Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Fostamatinib Major Product Offerings
7.3.4 Grifols Fostamatinib Sales and Revenue in Global (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 JW Pharmaceutical Corporation
7.4.1 JW Pharmaceutical Corporation Company Summary
7.4.2 JW Pharmaceutical Corporation Business Overview
7.4.3 JW Pharmaceutical Corporation Fostamatinib Major Product Offerings
7.4.4 JW Pharmaceutical Corporation Fostamatinib Sales and Revenue in Global (2018-2023)
7.4.5 JW Pharmaceutical Corporation Key News & Latest Developments
7.5 Medison Pharma Canada
7.5.1 Medison Pharma Canada Company Summary
7.5.2 Medison Pharma Canada Business Overview
7.5.3 Medison Pharma Canada Fostamatinib Major Product Offerings
7.5.4 Medison Pharma Canada Fostamatinib Sales and Revenue in Global (2018-2023)
7.5.5 Medison Pharma Canada Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Fostamatinib Major Product Offerings
7.6.4 AstraZeneca Fostamatinib Sales and Revenue in Global (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
8 Global Fostamatinib Production Capacity, Analysis
8.1 Global Fostamatinib Production Capacity, 2018-2029
8.2 Fostamatinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Fostamatinib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Fostamatinib Supply Chain Analysis
10.1 Fostamatinib Industry Value Chain
10.2 Fostamatinib Upstream Market
10.3 Fostamatinib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Fostamatinib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Fostamatinib in Global Market
Table 2. Top Fostamatinib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Fostamatinib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Fostamatinib Revenue Share by Companies, 2018-2023
Table 5. Global Fostamatinib Sales by Companies, (K Bottles), 2018-2023
Table 6. Global Fostamatinib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Fostamatinib Price (2018-2023) & (US$/Bottle)
Table 8. Global Manufacturers Fostamatinib Product Type
Table 9. List of Global Tier 1 Fostamatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fostamatinib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Fostamatinib Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Fostamatinib Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 15. By Type - Global Fostamatinib Sales (K Bottles), 2024-2029
Table 16. By Application – Global Fostamatinib Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Fostamatinib Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 20. By Application - Global Fostamatinib Sales (K Bottles), 2024-2029
Table 21. By Region – Global Fostamatinib Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Fostamatinib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Fostamatinib Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Fostamatinib Sales (K Bottles), 2018-2023
Table 25. By Region - Global Fostamatinib Sales (K Bottles), 2024-2029
Table 26. By Country - North America Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Fostamatinib Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Fostamatinib Sales, (K Bottles), 2018-2023
Table 29. By Country - North America Fostamatinib Sales, (K Bottles), 2024-2029
Table 30. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Fostamatinib Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Fostamatinib Sales, (K Bottles), 2018-2023
Table 33. By Country - Europe Fostamatinib Sales, (K Bottles), 2024-2029
Table 34. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Fostamatinib Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Fostamatinib Sales, (K Bottles), 2018-2023
Table 37. By Region - Asia Fostamatinib Sales, (K Bottles), 2024-2029
Table 38. By Country - South America Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Fostamatinib Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Fostamatinib Sales, (K Bottles), 2018-2023
Table 41. By Country - South America Fostamatinib Sales, (K Bottles), 2024-2029
Table 42. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Fostamatinib Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2018-2023
Table 45. By Country - Middle East & Africa Fostamatinib Sales, (K Bottles), 2024-2029
Table 46. Rigel Pharmaceuticals, Inc Company Summary
Table 47. Rigel Pharmaceuticals, Inc Fostamatinib Product Offerings
Table 48. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 49. Rigel Pharmaceuticals, Inc Key News & Latest Developments
Table 50. Kissei Pharmaceutical Co., Ltd Company Summary
Table 51. Kissei Pharmaceutical Co., Ltd Fostamatinib Product Offerings
Table 52. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 53. Kissei Pharmaceutical Co., Ltd Key News & Latest Developments
Table 54. Grifols Company Summary
Table 55. Grifols Fostamatinib Product Offerings
Table 56. Grifols Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 57. Grifols Key News & Latest Developments
Table 58. JW Pharmaceutical Corporation Company Summary
Table 59. JW Pharmaceutical Corporation Fostamatinib Product Offerings
Table 60. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 61. JW Pharmaceutical Corporation Key News & Latest Developments
Table 62. Medison Pharma Canada Company Summary
Table 63. Medison Pharma Canada Fostamatinib Product Offerings
Table 64. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 65. Medison Pharma Canada Key News & Latest Developments
Table 66. AstraZeneca Company Summary
Table 67. AstraZeneca Fostamatinib Product Offerings
Table 68. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (US$, Mn) and Average Price (US$/Bottle) (2018-2023)
Table 69. AstraZeneca Key News & Latest Developments
Table 70. Fostamatinib Production Capacity (K Bottles) of Key Manufacturers in Global Market, 2021-2023 (K Bottles)
Table 71. Global Fostamatinib Capacity Market Share of Key Manufacturers, 2021-2023
Table 72. Global Fostamatinib Production by Region, 2018-2023 (K Bottles)
Table 73. Global Fostamatinib Production by Region, 2024-2029 (K Bottles)
Table 74. Fostamatinib Market Opportunities & Trends in Global Market
Table 75. Fostamatinib Market Drivers in Global Market
Table 76. Fostamatinib Market Restraints in Global Market
Table 77. Fostamatinib Raw Materials
Table 78. Fostamatinib Raw Materials Suppliers in Global Market
Table 79. Typical Fostamatinib Downstream
Table 80. Fostamatinib Downstream Clients in Global Market
Table 81. Fostamatinib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Fostamatinib Segment by Type in 2022
Figure 2. Fostamatinib Segment by Application in 2022
Figure 3. Global Fostamatinib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Fostamatinib Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Fostamatinib Revenue, 2018-2029 (US$, Mn)
Figure 7. Fostamatinib Sales in Global Market: 2018-2029 (K Bottles)
Figure 8. The Top 3 and 5 Players Market Share by Fostamatinib Revenue in 2022
Figure 9. By Type - Global Fostamatinib Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Fostamatinib Revenue Market Share, 2018-2029
Figure 11. By Type - Global Fostamatinib Sales Market Share, 2018-2029
Figure 12. By Type - Global Fostamatinib Price (US$/Bottle), 2018-2029
Figure 13. By Application - Global Fostamatinib Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Fostamatinib Revenue Market Share, 2018-2029
Figure 15. By Application - Global Fostamatinib Sales Market Share, 2018-2029
Figure 16. By Application - Global Fostamatinib Price (US$/Bottle), 2018-2029
Figure 17. By Region - Global Fostamatinib Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Fostamatinib Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Fostamatinib Revenue Market Share, 2018-2029
Figure 20. By Region - Global Fostamatinib Sales Market Share, 2018-2029
Figure 21. By Country - North America Fostamatinib Revenue Market Share, 2018-2029
Figure 22. By Country - North America Fostamatinib Sales Market Share, 2018-2029
Figure 23. US Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Fostamatinib Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Fostamatinib Sales Market Share, 2018-2029
Figure 28. Germany Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 29. France Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Fostamatinib Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Fostamatinib Sales Market Share, 2018-2029
Figure 37. China Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 41. India Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Fostamatinib Revenue Market Share, 2018-2029
Figure 43. By Country - South America Fostamatinib Sales Market Share, 2018-2029
Figure 44. Brazil Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Fostamatinib Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Fostamatinib Sales Market Share, 2018-2029
Figure 48. Turkey Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Fostamatinib Revenue, (US$, Mn), 2018-2029
Figure 52. Global Fostamatinib Production Capacity (K Bottles), 2018-2029
Figure 53. The Percentage of Production Fostamatinib by Region, 2022 VS 2029
Figure 54. Fostamatinib Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ フォスタマチニブの世界市場見通し2023年-2029年(Fostamatinib Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

フォスタマチニブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp